MET-TARGETING CHIMERIC ANTIGEN RECEPTOR (METCAR) T CELL THERAPY IN HEPATOCELLULAR CARCINOMA

$579,103FY2019Department of the ArmyDOD

East Tennessee State University, Johnson City TN

Investigators